Trends in Psychostimulant and Antidepressant Use by Children in 2 Canadian Provinces

Abstract

French

Objective:

We used population-based administrative prescription medication data to examine regional differences in psychostimulant and antidepressant (AD) use among children from 2 Canadian provinces: British Columbia (BC) and Manitoba (MB).

Method:

Using 1997 to 2003 prescription data, annual rates of psychostimulant and AD use were determined for children aged 19 years and under in both provinces. Further comparisons of rates were made according to sex, age group, and specific classes of dispensed medications.

Results:

During 1997 to 2003, psychostimulant use rose by 44.9% in MB and 13.3% in BC. Among male children, psychostimulant use increased by 40.2% in MB, compared with an increase of only 8.6% in BC. AD utilization was similar between provinces, with increases of 80% and 75% in MB and BC, respectively. In both provinces, AD use was highest among older children.

Conclusions:

Our observations of regional variation in psychotropic medication use potentially reflect provincial differences in drug benefit policies, disease prevalence, and (or) physician diagnosis and treatment.

Keywords

drug use psychotropic drugs antidepressive agents methylphenidate amphetamines adolescent child drug prescriptions Manitoba British Columbia epidemiology

References

Zito

Safer

dosReis

Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med. 2003;157(1):17–25.

Guevara

Lozano

Wickizer

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics. 2002;109(5):733–739.

Olfson

Gameroff

Marcus

National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6):1071–1077.

Zuvekas

Vitiello

Norquist

. Recent trends in stimulant medication use among US children. Am J Psychiatry. 2006;163(4):579–585.

Vitiello

Zuvekas

Norquist

. National estimates of antidepressant medication use among US children, 1997–2002. J Am Acad Child Adolesc Psychiatry. 2006;45(3):271–279.

Gifford-Jones

Drugging children a sad and cruel sign of our times [Internet]. Toronto (ON): Canada Free Press; 2006 [cited 2008 Jan 8]. Available from: http://www.canadafreepress.com/medical/psychiatry062106.htm.

Kluger

Medicating young minds. TIME Magazine. 2003 Nov 3.

Tanner

Study shows surge in psychiatric drugs for young people. Chicago (IL): Associated Press, 2003 Jan 13.

Efron

Hiscock

Sewell

Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics. 2003;111(2):372–375.

10.

Vitiello

Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics. 2001;108:983–989.

11.

Ray

Schaffner

Federspiel

. Differences between female and male children in the receipt of prescribed psychotropic and controlled-analgesic drugs. A five-year epidemiologic study. Med Care. 1986;24(9):801–813.

12.

Zito

Safer

Riddle

Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol. 1998;8(2):99–105.

13.

van der Waals

Mohrs

Foets

Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ. 1993;307(6900):363–366.

14.

Zito

Safer

dosReis

Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull. 1997;33(1):143–147.

15.

Zito

Safer

dosReis

Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283(8):1025–1030.

16.

Rappley

Eneli

Mullan

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23(1):23–30.

17.

DeBar

Lynch

Powell

Use of psychotropic agents in preschool children: Associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med. 2003;157(2):150–157.

18.

Thomas

Conrad

Casler

Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatr Serv. 2006;57(1):63–69.

19.

Zito

Safer

dosReis

Rising prevalence of antidepressants among US youths. Pediatrics. 2002;109(5):721–727.

20.

Murray

de Vries

Wong

. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child. 2004;89(12):1098–1102.

21.

Schirm

Tobi

Zito

Psychotropic medication in children: A study from the Netherlands. Pediatrics. 2001;108(2):E25.

22.

Miller

Lalonde

McGrail

Prescription of methylphenidate to children and youth, 1990–1996. CMAJ. 2001;165(11):1489–1494.

23.

Ivis

Adlaf

. Prevalence of methylphenidate use among adolescents in Ontario. Can J Public Health. 1999;90(5):309–312.

24.

Brownell

Yogendran

. Attention-deficit hyperactivity disorder in Manitoba children: Medical diagnosis and psychostimulant treatment rates. Can J Psychiatry. 2001;46(3):264–272.

25.

Kozyrskyj

. Prescription medications in Manitoba children: Are there regional differences? Can J Public Health. 2002;93(Suppl 2):S63–S69.

26.

Rappley

Gardiner

Jetton

The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med. 1995;149(6):675–679.

27.

Jensen

Kettle

Roper

Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry. 1999;38(7):797–804.

28.

Cox

Motheral

Henderson

Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: Results from a commercially insured US sample. Pediatrics. 2003;111(2):237–243.

29.

Kozyrskyj

Mustard

. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998;32(11):1152–1157.

30.

Taylor

BTB

. A review of Ritalin prescribing by the College of Physicians and Surgeons of British Columbia [Internet]. Vancouver (BC): College of Physicians and Surgeons of British Columbia; 2000 [cited 2006 Dec 10]. Available from: https://www.cpsbc.ca/cps/general_info/communications/press_releases/2004/04/19_0404261228–250.

31.

BC PharmaCare. 2004. PharmaCare Trends 2003 [Internet]. Victoria (BC): BC Ministry of Health Services; 2004 [cited 2006 Dec 18]. Available from: http://www.health.gov.bc.ca/pharme/pharmacare_trends_2003.pdf.

32.

Zito

Safer

dosReis

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 1999;153(12):1257–1263.

33.

Health Canada. Important Safety Information Regarding Paxil in Pediatric Patients [Internet]. Ottawa (ON): Health Canada Public Advisory, Health Canada, 2003 [cited 2006 Dec 14]. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/public/2003/paxil_pa-ap_e.html.

34.

US Food and Drug Administration. FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees [Internet]. Rockville (MD): US FDA Public Advisory, US Department of Health and Human Services, 2004 [cited 2006 Dec 14]. Available from: http://www.fda.gov/bbs/topics/news/2004/NEW01116.html.

35.

Health Canada. Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressants [Internet]. Ottawa (ON): Health Canada Public Advisory, Health Canada, 2004 [cited 2006 Dec 14]. Available from: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2004/2004_02_e.html.